By Justin Petrone
NanoString Technologies has raised $20 million that it will use to advance its breast cancer test, prepare its nCounter Analysis System for clinical use, and develop new research applications for its platform, according to its top official.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.
The New York Times editorial board weighs in on scientific research misconduct.
The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.
The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.